XML 33 R22.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-based Compensation (Tables)
12 Months Ended
Dec. 31, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Estimated Weighted Average Grant Date Fair Value per Share

The Company granted options to purchase an aggregate of 433,700 and 500,350 shares of common stock in the years ended December 31, 2021 and 2020, respectively. The fair values of employee stock options granted in the years ended December 31, 2021 and 2020 were estimated at the date of grant using the Black-Scholes model with the following assumptions and had the following estimated weighted average grant date fair value per share:

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

Expected term

 

5.9 years

 

 

6.0 years

 

Expected volatility

 

 

94

%

 

 

96

%

Risk-free interest rate

 

 

1.08

%

 

 

0.50

%

Expected dividend yield

 

 

0

%

 

 

0

%

Weighted-average grant date fair value per share

 

$

2.09

 

 

$

3.28

 

 

 

Summary of Stock Option Activities

A summary of ARCA’s stock option activities for the years ended December 31, 2021 and 2020, and related information as of December 31, 2021, is as follows:

 

 

 

Options Outstanding

 

 

 

Number

of Options

 

 

Weighted Average

Exercise

Price

 

 

Weighted Average Remaining Contractual Term

(in years)

 

 

Aggregate Intrinsic Value

(in thousands)

 

Options outstanding - December 31, 2019

 

 

31,136

 

 

$

84.50

 

 

 

 

 

 

 

 

 

Granted

 

 

500,350

 

 

 

4.29

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited and cancelled

 

 

(248

)

 

 

610.46

 

 

 

 

 

 

 

 

 

Options outstanding - December 31, 2020

 

 

531,238

 

 

$

8.71

 

 

 

9.68

 

 

$

 

Granted

 

 

433,700

 

 

 

2.77

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited and cancelled

 

 

(60,815

)

 

 

12.71

 

 

 

 

 

 

 

 

 

Options outstanding - December 31, 2021

 

 

904,123

 

 

$

5.59

 

 

 

9.18

 

 

$

 

Options exercisable - December 31, 2021

 

 

159,164

 

 

$

15.91

 

 

 

8.21

 

 

$

 

Options vested and expected to vest -

       December 31, 2021

 

 

902,666

 

 

$

5.60

 

 

 

9.18

 

 

$

 

Summary of Non-cash, Share-based Compensation Expense

For the years ended December 31, 2021 and 2020, the Company recognized the following non-cash, share-based compensation expense (in thousands):

 

 

Years Ended

 

 

December 31,

 

 

2021

 

 

2020

 

Research and development

$

160

 

 

$

26

 

General and administrative

 

337

 

 

 

17

 

Total

$

497

 

 

$

43